Levine Cancer Institute launched the first mobile lung computed tomography unit designed to address lung cancer diagnosis, treatment and survival disparities for rural populations across the Carolinas.
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
